SCHEMBL9260209

SCHEMBL9260209

O=C(C#Cc1ccc(C(=O)O)cc1)Nc1ccccc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.57
RAB9A P51151 3/20 0.57
MEN1 O00255 3/20 0.57
KMT2A Q03164 3/20 0.57
POLB P06746 2/20 0.57
NLRP3 Q96P20 1/20 0.57
GFER P55789 1/20 0.57
PTPN11 Q06124 1/20 0.57
ALDH1A1 P00352 1/20 0.53
FFAR1 O14842 1/20 0.46
VCP P55072 1/20 0.46
RARB P10826 1/20 0.44
RARG P13631 1/20 0.44
PTPN1 P18031 1/20 0.43
GAA P10253 1/20 0.43
KDM4E B2RXH2 1/20 0.43
LMNA P02545 1/20 0.43
MAPT P10636 1/20 0.43
CASP3 P42574 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1250 0.88 NPC1 (0.71) NPC1RAB9AMEN1KMT2APOLB
SCHEMBL9261114 0.83 MEN1 (0.57) NPC1RAB9AMEN1KMT2APOLB
SCHEMBL30056471 0.83 RAB9A (0.61) NPC1RAB9AMEN1KMT2APOLB
Aniline SCHEMBL1444501 0.80 RAB9A (0.61) NPC1RAB9AMEN1KMT2APOLB
SCHEMBL9260524 0.80 SMN1; SMN2 (0.61) NPC1RAB9AMEN1KMT2APOLB
SCHEMBL30056033 0.80 RAB9A (0.89) NPC1RAB9AMEN1KMT2APOLB
SCHEMBL4104247 0.78 MEN1 (0.58) NPC1RAB9AMEN1KMT2APOLB
SCHEMBL9263110 0.77 NPC1 (0.70) NPC1RAB9AMEN1KMT2APOLB
SCHEMBL28302925 0.77 MEN1 (0.66) NPC1RAB9AMEN1KMT2APOLB
SCHEMBL402518 0.76 RARB (0.62) PTPN11FFAR1RARBRARGSLC16A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5411977-A Substituted 2,5-diaryl-4-isothiazolin-3-ones as antiinflammatory and antithrombotic agents THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) 1995-05-02 US disclosed